bottom-fishing $IONS

Its antisense technology platform has served as a springboard for drug discovery and realized hope for patients with unmet needs. Its broad, diverse pipeline has more than 40 potential first-in-class and/or best-in-class medicines designed to treat a broad range of diseases.